0,796  0,006  15-Lipoxygenase inhibitor
0,715  0,004  Genotoxic
0,698  0,024  Caspase 9 stimulant
0,672  0,011  Chemopreventive
0,649  0,009  UGT1A9 substrate
0,640  0,004  Monophenol monooxygenase inhibitor
0,671  0,036  Antiinflammatory
0,638  0,008  Lipoxygenase inhibitor
0,632  0,006  CYP1A2 inhibitor
0,637  0,025  Antineoplastic (lung cancer)
0,622  0,016  Aldehyde oxidase inhibitor
0,608  0,009  Cardioprotectant
0,604  0,010  NOS2 expression inhibitor
0,588  0,005  Skin whitener
0,586  0,009  Free radical scavenger
0,589  0,012  Antioxidant
0,607  0,034  Antineoplastic (breast cancer)
0,571  0,010  Antipyretic
0,569  0,019  Antihypercholesterolemic
0,589  0,052  Apoptosis agonist
0,566  0,035  Transcription factor NF kappa B inhibitor
0,535  0,005  Melanin inhibitor
0,536  0,012  Hypoglycemic
0,511  0,012  UGT1A6 substrate
0,518  0,019  12-Lipoxygenase inhibitor
0,507  0,010  Antimutagenic
0,508  0,019  Caspase 3 stimulant
0,501  0,014  Hypoxia-inducible factor 1 alpha inhibitor
0,503  0,022  Radioprotector
0,490  0,024  Hepatic disorders treatment
0,511  0,045  Alzheimer's disease treatment
0,501  0,040  CYP3A4 substrate
0,504  0,045  TNF expression inhibitor
0,466  0,014  UDP-glucuronosyltransferase substrate
0,500  0,050  Cyclophilin D inhibitor
0,500  0,050  Antidiabetic
0,463  0,026  CTGF expression inhibitor
0,461  0,026  Antiosteoporotic
0,453  0,019  UGT2B4 substrate
0,458  0,027  AR expression inhibitor
0,438  0,010  UGT1A3 substrate
0,433  0,005  Glutathione S-transferase substrate
0,433  0,006  UGT2B15 substrate
0,446  0,020  Nitric oxide antagonist
0,428  0,003  Gastritis treatment
0,454  0,036  Bone diseases treatment
0,446  0,028  NOS3 expression inhibitor
0,437  0,024  Antiprotozoal (Leishmania)
0,443  0,032  Spasmolytic
0,448  0,038  Ulceration
0,431  0,027  Antineoplastic (multiple myeloma)
0,433  0,029  Cytostatic
0,402  0,010  Topoisomerase II inhibitor
0,429  0,047  Antineoplastic (colorectal cancer)
0,422  0,046  Antineoplastic (colon cancer)
0,388  0,017  UGT1A4 substrate
0,388  0,018  UGT1A1 substrate
0,399  0,032  Antidiabetic (type 2)
0,405  0,038  Antineoplastic (brain cancer)
0,412  0,049  Prostate cancer treatment
0,398  0,036  Antineoplastic (glioma)
0,399  0,040  ICAM1 expression inhibitor
0,412  0,056  GABA C receptor rho-3 antagonist
0,383  0,032  Antiamyloidogenic
0,363  0,013  VCAM1 expression inhibitor
0,376  0,029  Antidiabetic symptomatic
0,384  0,039  Antineoplastic (cervical cancer)
0,375  0,033  Proliferative diseases treatment
0,359  0,018  Platelet adhesion inhibitor
0,409  0,072  5 Hydroxytryptamine release inhibitor
0,359  0,027  Peroxidase inhibitor
0,358  0,030  Antineoplastic (small cell lung cancer)
0,341  0,015  Tubulin antagonist
0,354  0,032  Vasodilator
0,354  0,035  Antineoplastic (glioblastoma multiforme)
0,322  0,005  Estrogen agonist
0,323  0,008  Heat shock protein 90 antagonist
0,328  0,012  CYP2B6 inhibitor
0,319  0,005  Estrogen receptor beta antagonist
0,393  0,079  Histamine release inhibitor
0,318  0,005  Estrogen antagonist
0,320  0,008  Cystathionine beta-synthase inhibitor
0,391  0,081  Antibacterial
0,320  0,011  Heat shock protein 90 alpha antagonist
0,340  0,034  Antimitotic
0,334  0,031  Antihypertriglyceridemic
0,371  0,073  Antileukemic
0,342  0,045  Sensitization
0,326  0,033  GST M1-1 substrate
0,370  0,080  Antipruritic, allergic
0,343  0,056  Antineoplastic (melanoma)
0,304  0,017  NOS3 expression enhancer
0,304  0,018  Lipid peroxidase inhibitor
0,320  0,034  Cyclic AMP phosphodiesterase inhibitor
0,306  0,021  Antineoplastic (squamous cell carcinoma)
0,294  0,011  5-Lipoxygenase inhibitor
0,343  0,060  CYP2D6 substrate
0,324  0,044  Cardiovascular analeptic
0,293  0,013  Nitric-oxide synthase stimulant
0,307  0,028  Antihypotensive
0,296  0,019  Antiischemic, cerebral
0,300  0,024  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,295  0,020  Protein-tyrosine phosphatase inhibitor
0,278  0,005  Postmenopausal disorders treatment
0,335  0,062  Antineoplastic (ovarian cancer)
0,299  0,027  UGT2B7 substrate
0,320  0,052  Chemoprotective
0,316  0,059  Antineoplastic (osteosarcoma)
0,314  0,061  CYP2C19 substrate
0,266  0,014  Protein-tyrosine phosphatase 1B inhibitor
0,299  0,051  Superoxide dismutase inhibitor
0,301  0,055  Transcription factor STAT inhibitor
0,309  0,067  5 Hydroxytryptamine release stimulant
0,296  0,055  Transcription factor STAT3 inhibitor
0,251  0,010  Alpha 2c adrenoreceptor antagonist
0,311  0,071  CYP3A4 inhibitor
0,255  0,015  SULT1A3 substrate
0,306  0,066  Lipoprotein disorders treatment
0,275  0,037  Hepatoprotectant
0,242  0,005  Keratolytic
0,252  0,016  Neuropathy treatment
0,327  0,096  CYP2C9 inhibitor
0,286  0,058  Platelet antagonist
0,249  0,022  LDLR expression enhancer
0,307  0,082  Vasodilator, coronary
0,261  0,039  Non-steroidal antiinflammatory agent
0,233  0,011  Topoisomerase II alpha inhibitor
0,239  0,018  VEGF expression inhibitor
0,257  0,037  Pneumotoxic
0,248  0,028  Amylase inhibitor
0,272  0,056  Cytotoxic
0,333  0,118  Analgesic
0,303  0,089  Calcium channel activator
0,248  0,036  Prostatic (benign) hyperplasia treatment
0,273  0,062  5 Hydroxytryptamine uptake stimulant
0,274  0,065  Antineoplastic (renal cancer)
0,292  0,087  Sodium/bile acid cotransporter inhibitor
0,236  0,031  MAO inhibitor
0,301  0,096  Vasodilator, peripheral
0,281  0,078  CYP1A2 substrate
0,222  0,019  Alpha 2b adrenoreceptor antagonist
0,207  0,004  Estrogen receptor beta agonist
0,229  0,026  NADPH oxidase inhibitor
0,207  0,009  Urease inhibitor
0,224  0,026  Acetylcholinesterase inhibitor
0,215  0,018  Antihemorrhagic
0,205  0,009  Actinic keratosis treatment
0,212  0,016  Antiemetic
0,212  0,016  CF transmembrane conductance regulator agonist
0,258  0,064  Antineoplastic (lymphoma)
0,211  0,016  Alpha 2 adrenoreceptor antagonist
0,264  0,072  Antineoplastic (non-small cell lung cancer)
0,255  0,064  Tyrosine 3 hydroxylase inhibitor
0,226  0,036  Cholinergic
0,207  0,017  SULT1A1 substrate
0,247  0,059  Amyloid beta aggregation inhibitor
0,203  0,016  Beta amyloid protein antagonist
0,193  0,007  SULT1E1 substrate
0,232  0,048  P-glycoprotein inhibitor
0,251  0,067  Antineoplastic (sarcoma)
0,207  0,025  GABA C receptor rho-2 antagonist
0,226  0,045  Sepsis treatment
0,238  0,057  RNA-directed DNA polymerase inhibitor
0,209  0,030  Carcinogenic, group 1
0,233  0,054  Abortion inducer
0,193  0,015  Alpha 2a adrenoreceptor antagonist
0,291  0,113  CYP2C9 substrate
0,205  0,028  MAO A inhibitor
0,212  0,037  Interferon gamma antagonist
0,207  0,032  UGT2B10 substrate
0,209  0,033  Antineoplastic (bone cancer)
0,184  0,009  Aromatase inhibitor
0,245  0,072  Angiogenesis stimulant
0,183  0,012  Prolactin inhibitor
0,185  0,014  Antineoplastic (uterine cancer)
0,321  0,150  Alpha-glucosidase inhibitor
0,207  0,036  UGT2B9 substrate
0,262  0,095  Respiratory analeptic
0,171  0,004  5 Hydroxytryptamine 2A agonist
0,223  0,057  Neurotrophic factor enhancer
0,233  0,066  Pyruvate kinase inhibitor
0,207  0,042  Antineoplastic (carcinoma)
0,174  0,009  Estrogen receptor alpha antagonist
0,191  0,029  Cholesterol synthesis inhibitor
0,206  0,044  Succinate dehydrogenase inhibitor
0,175  0,016  Chronic obstructive bronchitis treatment
0,190  0,032  Psychosexual dysfunction treatment
0,187  0,030  Topoisomerase I inhibitor
0,198  0,041  Antirickettsial
0,171  0,016  Creatine kinase inhibitor
0,215  0,060  Antimigraine
0,196  0,043  Protein kinase stimulant
0,188  0,036  Antifungal enhancer
0,194  0,042  Phobic disorders treatment
0,180  0,029  Farnesoid X receptor antagonist
0,264  0,114  Apoptosis antagonist
0,173  0,024  Choleretic
0,194  0,046  Antiviral (Influenza A)
0,189  0,044  Arachidonic acid antagonist
0,284  0,141  CYP2C19 inhibitor
0,173  0,030  MAO B inhibitor
0,246  0,106  Streptokinase A inhibitor
0,157  0,017  Electron transport complex I inhibitor
0,153  0,014  Dopamine D1 antagonist
0,161  0,025  UGT2B1 substrate
0,230  0,093  DNA damaging
0,155  0,023  Beta glucuronidase inhibitor
0,189  0,057  Antipruritic
0,166  0,035  Antihelmintic (Trematoda)
0,146  0,015  Dopamine agonist
0,150  0,021  DOPA decarboxylase inhibitor
0,202  0,073  Antiviral (Influenza)
0,213  0,085  Hypolipemic
0,283  0,155  Antiparkinsonian
0,144  0,023  5 Hydroxytryptamine agonist
0,140  0,020  UGT2B11 substrate
0,149  0,029  Antiviral (Influenza B)
0,150  0,031  Carbonic anhydrase XV inhibitor
0,125  0,006  5 Hydroxytryptamine 2 agonist
0,210  0,092  Antineoplastic (lymphocytic leukemia)
0,146  0,030  Carbonic anhydrase III inhibitor
0,186  0,071  Antipruritic, non-allergic
0,152  0,037  Alpha adrenoreceptor antagonist
0,144  0,031  Sulfotransferase substrate
0,231  0,117  Antiischemic
0,133  0,020  Macrophage migration inhibitory factor inhibitor
0,148  0,036  Antiadrenergic
0,135  0,023  NAD(P)H dehydrogenase (quinone) inhibitor
0,123  0,012  Alpha tubulin antagonist
0,146  0,036  Adrenaline antagonist
0,153  0,043  Antibacterial (Helicobacter pylori)
0,258  0,149  Antiobesity
0,143  0,034  HDL-cholesterol increasing
0,181  0,073  Diabetic nephropathy treatment
0,125  0,016  Beta tubulin antagonist
0,197  0,089  Antiparasitic
0,184  0,076  Antihelmintic
0,128  0,020  Ornithine decarboxylase inhibitor
0,226  0,119  Analeptic
0,111  0,006  Glutamate (mGluR7) antagonist
0,126  0,024  Antiviral (Rhinovirus)
0,136  0,035  Antifungal (Pneumocystis)
0,224  0,123  Antihypoxic
0,148  0,048  Ca2+-transporting ATPase inhibitor
0,109  0,009  Estradiol 17 beta-dehydrogenase inhibitor
0,247  0,150  Immunosuppressant
0,154  0,057  Renal failure treatment
0,140  0,042  DNA repair enzyme inhibitor
0,157  0,060  Antiprotozoal (Coccidial)
0,222  0,125  Antidepressant
0,137  0,040  Xanthine oxidase inhibitor
0,238  0,141  FMO1 substrate
0,110  0,016  Aldose reductase inhibitor
0,134  0,040  GABA C receptor antagonist
0,189  0,096  Cardiodepressant
0,118  0,026  5 Hydroxytryptamine 1A antagonist
0,189  0,097  Antialcoholic
0,099  0,011  Dopamine D2 agonist
0,161  0,074  Prostate disorders treatment
0,142  0,056  Cyclooxygenase 3 inhibitor
0,164  0,080  Mutagenic
0,095  0,011  Leukotriene B4 antagonist
0,140  0,060  Interleukin 4 antagonist
0,103  0,022  SULT1A2 substrate
0,147  0,067  MAP kinase kinase 4 inhibitor
0,130  0,051  Microtubule formation inhibitor
0,104  0,026  Histone deacetylase stimulant
0,104  0,026  Histone deacetylase SIRT1 stimulant
0,100  0,022  Leukotriene antagonist
0,216  0,141  Mood disorders treatment
0,135  0,063  Antiseptic
0,102  0,030  Na+ K+ transporting ATPase inhibitor
0,146  0,076  Antidiarrheal
0,262  0,193  Calcium channel L-type activator
0,141  0,073  Mannose-6-phosphate isomerase inhibitor
0,122  0,055  Photosensitizer
0,112  0,045  Breast cancer-resistant protein inhibitor
0,220  0,154  Antithrombotic
0,069  0,004  Estrogen-related receptor beta antagonist
0,127  0,064  Aldehyde dehydrogenase inhibitor
0,140  0,077  Heat shock protein 70 antagonist
0,104  0,042  Bile acid receptor antagonist
0,066  0,005  Sodium/glucose cotransporter 2 inhibitor
0,077  0,015  Postcoital contraceptive
0,110  0,049  Anabolic
0,140  0,079  Acaricide
0,110  0,050  GABA C receptor rho-1 antagonist
0,083  0,023  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,142  0,083  Phospholipase A2 inhibitor
0,097  0,038  5 Hydroxytryptamine 1 antagonist
0,095  0,036  D-Ala-D-Ala ligase inhibitor
0,093  0,035  Estrogen-related receptor beta agonist
0,121  0,067  Alkylator
0,090  0,036  Histidine decarboxylase inhibitor
0,101  0,047  Alpha 2d adrenoreceptor antagonist
0,095  0,042  Carbonic anhydrase VI inhibitor
0,172  0,120  Antiviral (Ebola)
0,084  0,032  Phosphodiesterase III inhibitor
0,108  0,056  Antihypermotility
0,125  0,075  Cyclooxygenase 1 inhibitor
0,065  0,014  Estrogen receptor alpha agonist
0,058  0,008  Melatonin 2 agonist
0,121  0,072  Coagulant
0,099  0,051  ABCA1 expression enhancer
0,135  0,087  Antifungal (Cryptococcus)
0,178  0,131  Antineoplastic (liver cancer)
0,090  0,043  Carbonic anhydrase XIII inhibitor
0,089  0,043  Dopamine antagonist
0,075  0,029  Protease activated receptor antagonist
0,084  0,038  Peroxisome proliferator-activated receptor gamma agonist
0,118  0,073  Contraceptive female
0,092  0,047  Granulocyte macrophage colony stimulating factor agonist
0,095  0,050  Androgen antagonist
0,085  0,040  Narcotic antagonist
0,094  0,049  Antineoplastic antibiotic
0,139  0,095  Aldose reductase substrate
0,063  0,019  5 Hydroxytryptamine 2C agonist
0,094  0,050  Phosphodiesterase IV inhibitor
0,121  0,078  Antihyperlipoproteinemic
0,121  0,078  Papain-like protease (SARS coronavirus) inhibitor
0,109  0,066  Mucolytic
0,108  0,066  Chelator
0,047  0,005  Sodium/glucose cotransporter inhibitor
0,103  0,062  Gastric antisecretory
0,072  0,032  Neuraminidase inhibitor
0,060  0,021  Potassium channel Kv1.3 blocker
0,079  0,040  Dopamine D2 antagonist
0,143  0,104  Carcinogenic
0,064  0,026  Ryanodine receptor antagonist
0,107  0,069  Endometrios treatment
0,122  0,084  Vanilloid 1 agonist
0,094  0,056  Thioredoxin inhibitor
0,147  0,110  Neurotensin receptor agonist
0,130  0,094  Antidote
0,068  0,033  Transcription factor RelA inhibitor
0,051  0,015  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,095  0,060  HIV-1 integrase (Overall Integration) inhibitor
0,093  0,058  Paget's disease treatment
0,170  0,135  Tumour necrosis factor alpha release inhibitor
0,117  0,081  Toll-Like receptor 2 antagonist
0,045  0,011  Liver X receptor antagonist
0,042  0,009  Dopamine autoreceptor agonist
0,099  0,068  Carcinogenic, group 2B
0,107  0,076  TRPA1 agonist
0,071  0,041  SULT2A1 substrate
0,083  0,053  Thioredoxin reductase inhibitor
0,074  0,044  Secretase beta inhibitor
0,034  0,004  NMDA receptor phencyclidine site antagonist
0,048  0,019  Dopamine D5 agonist
0,170  0,141  Vascular (periferal) disease treatment
0,095  0,066  Sphingomyelinase inhibitor
0,062  0,033  Fatty acid synthase inhibitor
0,145  0,117  Phospholipase C inhibitor
0,072  0,044  Alpha adrenoreceptor agonist
0,185  0,158  Antineoplastic (bladder cancer)
0,206  0,179  GST A substrate
0,187  0,160  Antifungal
0,168  0,141  Myocardial infarction treatment
0,101  0,076  Multidrug resistance-associated protein 1 inhibitor
0,044  0,019  Cholesterol absorption inhibitor
0,073  0,048  Glycine receptor agonist
0,089  0,064  Glutamate release inhibitor
0,071  0,046  Anticholelithogenic
0,108  0,083  M18 aspartyl aminopeptidase inhibitor
0,046  0,022  DNA gyrase subunit A inhibitor
0,103  0,079  Nav1.5 sodium channel blocker
0,082  0,058  Antiprotozoal activity enhancer
0,082  0,059  Protein kinase A inhibitor
0,032  0,009  Sodium/glucose cotransporter 1 inhibitor
0,066  0,044  Aryl hydrocarbon receptor antagonist
0,080  0,058  Adrenaline agonist
0,038  0,017  Melatonin 1 agonist
0,064  0,043  HIV-1 integrase (3'-Processing) inhibitor
0,102  0,082  Antitussive
0,075  0,055  Antitreponemal
0,095  0,075  Expectorant
0,062  0,043  Prolactin release inhibitor
0,057  0,038  Leukotriene C antagonist
0,037  0,018  Melatonin agonist
0,087  0,069  Restless leg syndrome treatment
0,065  0,047  Beta adrenoreceptor antagonist
0,082  0,064  mTOR complex 2 inhibitor
0,080  0,063  Carcinogenic, group 2A
0,035  0,018  Nucleoside transporters inhibitor
0,052  0,035  Glucose-6-phosphate translocase inhibitor
0,059  0,044  Alpha 2 adrenoreceptor agonist
0,097  0,083  GST T1-1 substrate
0,018  0,005  Antibiotic Tetracycline-like
0,055  0,042  Xanthine dehydrogenase inhibitor
0,174  0,161  5 Hydroxytryptamine 1E antagonist
0,026  0,013  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,099  0,087  DNA polymerase I inhibitor
0,078  0,065  Calcium antagonist
0,025  0,012  Leukotriene B4 receptor 2 antagonist
0,040  0,028  Neurokinin 1 antagonist
0,051  0,041  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,086  0,075  Butyrylcholinesterase inhibitor
0,046  0,036  Cholesterol esterase inhibitor
0,155  0,145  Antineoplastic enhancer
0,032  0,022  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,024  0,014  Dopamine D1 agonist
0,032  0,023  Estrogen-related receptor alpha antagonist
0,040  0,032  Dopamine D5 antagonist
0,053  0,045  Plasminogen activator inhibitor
0,024  0,017  Protein 30S ribosomal subunit inhibitor
0,119  0,112  Insulin secretagoues
0,098  0,091  Proteasome inhibitor
0,020  0,014  Retinoic acid alpha receptor antagonist
0,026  0,021  Leukotriene B4 receptor 1 antagonist
0,139  0,134  Catenin beta inhibitor
0,067  0,062  Alpha 1 adrenoreceptor antagonist
0,060  0,055  Leukotriene synthesis inhibitor
0,059  0,055  Neuraminidase (influenza) inhibitor
0,052  0,048  Alpha 1 adrenoreceptor agonist
0,097  0,094  Acetylcholine release stimulant
0,076  0,074  Ca(v)3.1 blocker
0,051  0,049  HIV-1 integrase (Strand Transfer) inhibitor
0,049  0,047  Lysine-specific demethylase 1A inhibitor
0,134  0,132  Psychostimulant
0,147  0,146  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,035  0,034  Substance P antagonist
0,059  0,059  Uterine relaxant

